Echocardiography is the cornerstone imaging modality for diagnosing hypertrophic cardiomyopathy and stratifying patient risk for sudden cardiac death, heart failure, atrial fibrillation, and stroke.
Echocardiography, augmented by advanced techniques like strain imaging and 3D echocardiography, is essential for the comprehensive evaluation and risk stratification of patients with hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is the most frequent cardiac disease with genetic substrate, affecting about 0.2-0.5% of the population. While most of the patients with HCM have a relatively good prognosis, some are at increased risk of adverse events. Identifying such patients at risk is important for optimal treatment and follow-up. While clinical and electrocardiographic information plays an important role, echocardiography remains the cornerstone in assessing patients with HCM. In this review, we discuss the role of echocardiography in diagnosing HCM, the key features that differentiate HCM from other diseases and the use of echocardiography for risk stratification in this setting (risk of sudden cardiac death, heart failure, atrial fibrillation and stroke). The use of modern echocardiographic techniques (deformation imaging, 3D echocardiography) refines the diagnosis and prognostic assessment of patients with HCM. The echocardiographic data need to be integrated with clinical data and other information, including cardiac magnetic resonance, especially in challenging cases or when there is incomplete information, for the optimal management of these patients.
Mandeş et al. (Thu,) conducted a review in Hypertrophic cardiomyopathy. Echocardiography was evaluated. Echocardiography is the cornerstone imaging modality for diagnosing hypertrophic cardiomyopathy and stratifying patient risk for sudden cardiac death, heart failure, atrial fibrillation, and stroke.